Autolus to Present at Upcoming Investor Conferences
PR Newswire
LONDON, Aug. 30, 2018
LONDON, Aug. 30, 2018 /PRNewswire/ -- Autolus Therapeutics plc AUTL, a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that management will be participating in the following, upcoming investor conferences:
- Dr. Christian Itin, chief executive officer, will present at the Wells Fargo 13th Annual Healthcare Conference on Wednesday, September 5, at 9:40 a.m. ET in Boston, MA. A webcast of the presentation will be available on the investor relations section of the company's website: https://www.autolus.com
- Christopher Vann, chief operating officer, will present at the H.C. Wainwright 20th Annual Global Investment Conference on Thursday, September 6, at 3:50 p.m. ET in New York, NY
- Dr. Itin will present at the 16th Annual Morgan Stanley Global Healthcare Conference on Wednesday, September 12, at 3:50 p.m. ET in New York, NY. A webcast of the company's fireside chat will be available on the investor relations section of Autolus' website: https://www.autolus.com
About Autolus Therapeutics plc
Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors. For more information, go to: https://www.autolus.com
Investor Contact: |
International Media Contact: |
U.S. Media Contact: |
S.A. Noonan Communications, LLC |
JW Communications |
Rx Communications Group, LLC |
Susan A. Noonan |
Julia Wilson |
Paula Schwartz |
+1-212-966-3650 |
+44 (0)7818 430877 |
+ 1-917-322-2216 |
View original content with multimedia:http://www.prnewswire.com/news-releases/autolus-to-present-at-upcoming-investor-conferences-300704778.html
SOURCE Autolus Therapeutics plc
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.